107 related articles for article (PubMed ID: 8177534)
1. Neuroprotective effect of cholecystokininB receptor antagonist on ischemia-induced decrease in CA1 presynaptic fiber spikes in rat hippocampal slices.
Minamoto Y; Tanaka T; Shibata S; Watanabe S
Neurosci Lett; 1994 Feb; 167(1-2):81-4. PubMed ID: 8177534
[TBL] [Abstract][Full Text] [Related]
2. Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices.
Yamamoto Y; Tanaka T; Shibata S; Watanabe S
Brain Res; 1994 Nov; 665(1):151-4. PubMed ID: 7882009
[TBL] [Abstract][Full Text] [Related]
3. Facilitatory effect of vasopressin on the ischemic decrease of the CA1 presynaptic fiber spikes in rat hippocampal slices.
Tanaka T; Shishido Y; Shibata S; Watanabe S
Brain Res; 1994 May; 644(2):343-6. PubMed ID: 8050047
[TBL] [Abstract][Full Text] [Related]
4. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of 5-HT3 receptor antagonist on ischemia-induced decrease in CA1 field potential in rat hippocampal slices.
Kagami Y; Shigenobu S; Watanabe S
Eur J Pharmacol; 1992 Nov; 224(1):51-6. PubMed ID: 1451743
[TBL] [Abstract][Full Text] [Related]
6. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
7. CCKB receptor activation protects CA1 neurons from ischemia-induced dysfunction in stroke-prone spontaneously hypertensive rats hippocampal slices.
Yasui M; Kawasaki K
Neurosci Lett; 1995 May; 191(1-2):99-102. PubMed ID: 7659302
[TBL] [Abstract][Full Text] [Related]
8. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.
Dunlop J; Brammer N; Evans N; Ennis C
Biochem Pharmacol; 1997 Jul; 54(1):81-5. PubMed ID: 9296353
[TBL] [Abstract][Full Text] [Related]
9. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
[TBL] [Abstract][Full Text] [Related]
11. A role of sigma receptors on hypoxia/hypoglycemia-induced decrease in CA1 presynaptic fiber spikes in rat hippocampal slices.
Shibata S; Yamamoto Y; Watanabe S
Brain Res; 1995 Jan; 670(2):337-41. PubMed ID: 7743202
[TBL] [Abstract][Full Text] [Related]
12. The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
Bickerdike MJ; Marsden CA; Dourish CT; Fletcher A
Eur J Pharmacol; 1994 Dec; 271(2-3):403-11. PubMed ID: 7705440
[TBL] [Abstract][Full Text] [Related]
13. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
Varga G; Scarpignato C
Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
[TBL] [Abstract][Full Text] [Related]
14. NG-nitro-L-arginine protects against hypoxia/hypoglycemia-induced decrease in CA1 presynaptic spikes in rat hippocampal slices.
Shibata S; Yamamoto Y; Tanaka T; Watanabe S
Eur J Pharmacol; 1995 Feb; 273(3):223-8. PubMed ID: 7537683
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of gastrin-induced gastric acid secretion by antisense oligonucleotide to the CCKB/gastrin receptor.
Rao RK; Lopez Y; Lai J; Riviere PJ; Junien JL; Porreca F
Neuroreport; 1995 Nov; 6(17):2373-7. PubMed ID: 8747156
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
Taniguchi H; Yazaki N; Endo T; Nagasaki M
Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
[TBL] [Abstract][Full Text] [Related]
18. CCKB-receptor activation augments the long-term potentiation in guinea pig hippocampal slices.
Yasui M; Kawasaki K
Jpn J Pharmacol; 1995 Aug; 68(4):441-7. PubMed ID: 8531419
[TBL] [Abstract][Full Text] [Related]
19. Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transport.
Rao RK; Levenson S; Fang SN; Hruby VJ; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1994 Feb; 268(2):1003-9. PubMed ID: 8113956
[TBL] [Abstract][Full Text] [Related]
20. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
